A Phase 2 Multicenter, Randomized, Double-masked, Sham-controlled, Reference-arm Study to Evaluate Efficacy and Safety of ONL1204 in Patients With Geographic Atrophy (GA) Associated With Age-related Macular Degeneration (AMD)
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
ONL Therapeutics
Start Date
October 15, 2025
End Date
October 14, 2030
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
ONL Therapeutics
Start Date
October 15, 2025
End Date
October 14, 2030